REDWOOD CITY, Calif., Nov. 16, 2017 /PRNewswire/ -- Guardant Health has added Bristol-Myers Squibb Company to the group of
Development of GuardantOMNI
"Our agreement with Guardant Health will allow us to further explore genomic biomarkers as we advance our clinical-stage pipeline," said Bruce Car, head of translational sciences at Bristol-Myers Squibb. "Non-invasive methods of acquiring tumor DNA will provide more data, potentially leading to greater insights into patient response."
"We are excited Bristol-Myers Squibb has joined the development of GuardantOMNI," said Helmy Eltoukhy, Guardant Health Co-Founder and CEO. "Circulating-tumor DNA has the potential to help drive our understanding, drug discovery, and trial enrollment across all types of oncology programs. As an expert in immuno-oncology and translational science, Bristol-Myers Squibb is an ideal company to work with in developing GuardantOMNI."
About Guardant Health
Guardant Health is focused on conquering cancer by using its breakthrough blood-based assays, vast data sets, and advanced analytics. Using both molecular and digital tools, Guardant Health is addressing challenges across the cancer care continuum. The company has raised more than $500 million from leading investors. Its first product, the Guardant360 assay, came to market in 2014, and is now the most widely ordered comprehensive liquid biopsy commercially available. In 2016, it announced Project LUNAR, an effort to apply Guardant Health's technology platform to early detection, recurrence monitoring, and assessing minimal residual disease. Guardant Health and Guardant360 are registered trademarks of Guardant Health, Inc.
View original content:http://www.prnewswire.com/news-releases/guardant-health-expands-support-for-the-development-of-the-guardantomni-assay-through-new-agreement-with-bristol-myers-squibb-300557941.html
SOURCE Guardant Health
Subscribe to our Free Newsletters!
Urinary retention is a condition where a person is unable to voluntarily empty the urinary bladder ...
Hashimoto's thyroiditis is an autoimmune disorder of the thyroid causing hypothyroidism. Synthetic ...
Strokes occur when blood flow to an area of the brain is cut off. It is imperitive to detect the ...View All